7/5/22 16:30 | 6/30/22 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | FL | DO | CEO | S.dm | -560 | 18.80 | 0 | -30 | -25 | 89 | D | | | | | | | | | | | | | | |
3/11/21 17:51 | 3/9/21 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | NY | DO | CEO | S.dm | -355 | 35.48 | 0 | -10 | -10 | 89 | D | | | | | | | | | | | | | | |
2/26/21 16:50 | 2/24/21 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | NY | DO | CEO | S.d | -342 | 34.24 | 0 | -10 | -10 | 89 | D | | | | | | | | | | | | | | |
2/16/21 17:10 | 2/11/21 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | NY | DO | CEO | S.d | -51 | 35.43 | 0 | -1 | -2 | 89 | D | | | | | | | | | | | | | | |
2/10/21 19:25 | 2/8/21 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | NY | DO | CEO | S.dm | -394 | 35.17 | 0 | -11 | -11 | 89 | D | | | | | | | | | | | | | | |
2/4/21 17:40 | 2/2/21 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | NY | DO | CEO | S.dm | -115 | 35.07 | 0 | -3 | -4 | 89 | D | | | | | | | | | | | | | | |
1/29/21 17:22 | 1/27/21 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | NY | DO | CEO | S.d | -324 | 32.39 | 0 | -10 | -12 | 75 | D | | | | | | | | | | | | | | |
1/26/21 19:29 | 1/22/21 | RLMD | Relmada Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Traversa Sergio | NY | DO | CEO | S.dm | -144 | 35.43 | 0 | -4 | -5 | 75 | D | | | | | | | | | | | | | | |